Deal facts
- Buyer
- company owned by Luis Collantes
- Target
- Creo Medical SL
- Deal value
- Not disclosed
- Announced
- 22 May 2026
- Status
- Possible offer
- Sector
- Healthcare
- Country
- Spain
- Consideration
- cash
Sources
A company owned by Luis Collantes has agreed to acquire a minority stake in Creo Medical SL, a healthcare business based in Spain. The transaction involves cash consideration, though the specific financial value remains undisclosed. This deal was announced on 22 May 2026 and is currently classified as a possible offer. The target operates within the healthcare sector, while the buyer's country of origin is not reported in available records.
The acquisition represents a strategic entry into the Spanish healthcare market through a minority investment rather than a full takeover. As the deal is still in the early stages, it remains subject to further developments before any final agreement is reached. The transaction is subject to regulatory approval and further due diligence before completion.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- Possible offer
Proposed Sale of 49% Interest in Creo Medical SL
Disclaimer* THIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 AS THEY FORM PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. WITH THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. Creo Medical Group plc ("Cr
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
YA II PN, LTD to acquire JUPITER NEUROSCIENCES, INC.
YA II PN, LTD and JUPITER NEUROSCIENCES, INC. entered the Exit Mode archive.
- Buyer
- YA II PN, LTD
- Target
- JUPITER NEUROSCIENCES, INC.
- Deal value
- USD 1,860,000
- Deal type
- minority stake
EQT FUNDS to acquire CORZA BIOSURGERY BUSINESS
EQT Funds has agreed to acquire the Corza Biosurgery Business in a private equity acquisition. This transaction involves the purchase of the healthcare-focused entity by…
- Buyer
- EQT FUNDS
- Target
- CORZA BIOSURGERY BUSINESS
- Deal value
- Not disclosed
- Deal type
- pe acquisition
Dolby Medical Home Respiratory Care Limited (Vivisol) to acquire Air Liquide Healthcare Limited’s home oxygen services business
Dolby Medical Home Respiratory Care Limited, trading as Vivisol, has agreed to acquire the home oxygen services business of Air Liquide Healthcare Limited in a strategic…
- Buyer
- Dolby Medical Home Respiratory Care Limited (Vivisol)
- Target
- Air Liquide Healthcare Limited’s home oxygen services business
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
RSLGH, LLC to acquire RYTHM, Inc.
RSLGH, LLC has agreed to acquire RYTHM, Inc., a healthcare company based in the United States, in a strategic acquisition valued at $109.5 million. The transaction invol…
- Buyer
- RSLGH, LLC
- Target
- RYTHM, Inc.
- Deal value
- USD 109,500,000
- Deal type
- strategic acquisition
Ensysce Biosciences, Inc. to acquire Cy Biopharma, Inc.
Ensysce Biosciences, Inc. has agreed to acquire Cy Biopharma, Inc. in a strategic acquisition within the healthcare sector. The transaction was announced on 5 August 202…
- Buyer
- Ensysce Biosciences, Inc.
- Target
- Cy Biopharma, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
company owned by Luis Collantes
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive